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Introduction: National chronic dialysis 
data are fundamental for treatment 
planning. Objective: To report data of 
the annual survey of the Brazilian So-
ciety of Nephrology about chronic kid-
ney disease patients on dialysis in July 
2012. Methods: A survey based on data 
of dialysis units from the whole coun-
try. The data collection was performed 
by using a questionnaire filled out 
on-line by the dialysis units in Brazil. 
Results: 255 (31.9%) of the dialysis units 
in the country answered the question-
naire. In July 2012, the total estimated 
number of patients on dialysis in the 
country was 97,586. The estimated prev-
alence and incidence rates of chronic kid-
ney disease on maintenance dialysis were 
503 and 177 patients per million popula-
tion, respectively. The estimated number 
of new patients starting dialysis in 2012 
was 34,366. The annual gross mortality 
rate was 18.8%. For prevalent patients, 
31.9% were aged 65 years or older, 
91.6% were on hemodialysis and 8.4% 
on peritoneal dialysis, 30,447 (31.2%) 
were on a waiting list of renal transplant, 
28.5% were diabetics, 36.6% had serum 
phosphorus > 5.5 mg/dl and 34.4% 
hemoglobin < 11 g/dl. A venous catheter 
was the vascular access for 14.5% of the 
hemodialysis patients. Conclusion: The 
prevalence and incidence rates of chronic 
kidney disease patients on dialysis in-
creased, while the mortality rate tended 
to decrease compared with 2011. The 
indicators of the quality of maintenance 
dialysis remained stable with a trend to-
wards decrease in levels of anemia. The 
data highlight the importance of the cen-
sus to guide chronic dialysis therapy.
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intRoduction
The Brazilian Society of Nephrology 
(SBN) has been leading a national 
census on patients with chronic kidney 
disease undergoing dialysis for more 
than 10 years, from information 
provided by dialysis facilities registe-
red in the entity. This information has 
provided knowledge on several epide-
miological aspects of patients on chro-
nic dialysis treatment in the country 
and their trends over the years; and it 
has provided subsidies for dialogues 
with the government and other pro-
viders of such treatment to plan the 
care for these patients. This impor-
tant activity of the Brazilian Society of 
Nephrology has been carried out with 
the voluntary cooperation of dialysis 
centers across the country. In this 
report, we present data concerning the 
dialysis patients’ situation on July 1, 
2012, as well as some comparisons 
with previous years.
mEthods
During the second half of 2012, a 
survey was carried out on patients with 
chronic kidney disease on outpatient 
dialysis in all units in the country 
registered at SBN. From August to 
October of 2012, a record with the 
issues of this study became available 
on the SBN website on the Internet and 
all dialysis units in the country were 
requested to fill out the questionnaire 
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and submit their data online to the SBN secretary. 
Every month, the units which had not yet 
submitted their data were requested to fill out the 
form until the established due date (October 30, 
2012). When necessary, data was obtained or 
confirmed by telephone interview through the 
SBN secretariat responsible for the dialysis unit. 
Questions on most sociodemographical, clinical, 
laboratory and treatment aspects referred to 
dialysis patients on July 1, 2012. Mortality data 
and the entry of new dialysis patients involved the 
month of July 2012 and estimates were made for 
the entire year.
From the 696 dialysis units registered at 
SBN in July 2012, 651 had active program for 
chronic dialysis, and 255 (39.1%) of these com-
pleted the questionnaire and had their data 
analyzed. The data was computed from 38,198 
patients in 255 participating dialysis units. The 
data sent by the centers was collected in groups 
rather than individually from each patient, and 
should therefore be interpreted as representing 
averages of patient characteristics and treatment 
practices prevalent in each dialysis unit. National 
data was estimated taking into account the 
numbers expected from the centers that did 
not respond to the survey, as per their regional 
location. The units that did not respond to the 
census were assigned the average number of 
patients expected for that region and their total 
computed in estimates. Population estimates from 
Brazil and from every region of the country used 
in the calculation of prevalence and incidence 
were made from updated IBGE estimates for July 
2012. Using the pooled data we estimated the 
percentage of patients outside the recommended 
target indexes,1,2 for dialysis dose (for Kt/V or 
urea reduction ratio) and serum concentrations of 
albumin, phosphorus, PTH and hemoglobin.
REsults
The total number of active units increased 
slightly in 2012 compared to 2011 (651 and 643, 
respectively). Figure 1 shows the distribution 
of active units that responded to the census by 
Figure 1. Distribution of the dialysis units that responded to the 
census (n = 255) by region, 2012 census.
region. The proportion of units that responded in 
relation to the total number of active ones was 
similar between the various regions of the country, 
mostly located in the Southeast, followed by the 
South and Northeast. The number of patients 
who responded at the 255 units was 38,198. 
From the total of these patients, 83.9% had their 
treatments paid by the Public Health Care System 
(SUS) and 16.1% by private health insurance.
The estimated total number of dialysis patients 
in the country on July 1st, 2012 was 97,586. The 
number has increased gradually over the years: 
42,695 in the year 2000; 92,091 in 2010 and 
91,314 in 2011. There was an annual increase 
of 3% per year compared to 2010. More than 
half of these patients were in the Southeast. 
The prevalence rate of dialysis in 2012 was 503 
patients per million of the population (pmp), 
varying by region among 291 patients pmp in the 
North to 630 patients pmp in the Midwest region 
(Figure 2). The overall increase in the prevalence 
rate was almost 6% when compared to 2011, when 
this rate was 475/pmp. The estimated number of 
patients who started treatment in 2012 in Brazil 
was 34,366, corresponding to an incidence rate 
of 177 patients pmp (Figure 3). Over 50% of the 
patients (n = 18,072) initiated treatment in the 
Southeast region; 6,051 patients started dialysis 
in the Northeast; 5,963 in the South region; 2,733 
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Figure 2. Estimated prevalence of patients on dialysis in Brazil, per 
region, 2012 census.
Figure 3. Estimated incidence of patients on dialysis in Brazil, by 
region, census 2012.
tablE 1 patiENt distributioN accordiNg to thE  
 typE of dialysis aNd payiNg ENtity, cENsus  
 2012
Mode
SUS 
N (%)
Not SUS 
N (%)
Total 
N (%)
HD 
conventional
29,459 
(91.9)
5,285 
(85.9)
34,744 
(91.0)
HD daily 
(> 4x/sem.)
62 (0.2) 174 (2.8) 236 (0.6)
CAPD 1,169 (3.6) 208 (3.4) 1,377 (3.6)
APD 1,333 (4.2) 482 (7.8) 1,815 (4.8)
IPD 25 (0.1) 1 (0.0) 26 (0.1)
Total 32,048 (100) 6,150 (100) 38,198 (100)
in the Midwest region and 1,480 in the North. 
The annual incidence rate of treatment ranged 
from 91 pmp in the Northern region to 222 pmp 
in the Southeast (Figure 3). These estimates are 
substantially higher than those observed in 2011, 
when 26,680 new patients started treatment 
(149/ pmp).3
The percentage of dialysis patients with 12 
years of age or less; between 13 and 18; 19 to 
64 years;, 65-80 years or > 80 years were 0.3%, 
4.2%, 63.6%, 27.7% and 4.2%, respectively. 
What stands out is the percentage of children 
which increased when compared to 2011 (1.6%), 
while the percentage of the elderly did not change 
(4.3% in 2011). Fifty-eight percent of patients 
were males.
In July 2012, 91.6% of the patients on chronic 
dialysis were being treated by hemodialysis 
and 8.4% were on peritoneal dialysis, and of 
these, automated peritoneal dialysis was the 
predominant treatment mode. Table 1 shows the 
distribution of patients according to the type of 
dialysis and payment source, a higher percentage 
of patients paid by health insurance were on daily 
hemodialysis and peritoneal dialysis, particularly 
the APD in relation to those reimbursed by the 
SUS. In the Public Health Care System, 7.9% of 
the patients were on peritoneal dialysis compared 
to 11.2% - who had their treatment paid by 
private health insurance companies.
Regarding the diagnosis of primary renal 
disease, the most common were associated 
with hypertension (34%) and diabetes (29%), 
followed by chronic glomerulonephritis (13%) 
and polycystic kidneys (4%), other diagnoses 
were made in 11% and this was not defined in 
10% of the cases.
The prevalence of positive serology for 
hepatitis B and C virus in patients maintained on 
chronic dialysis in Brazil was 4.6% and 1.0%, 
respectively, and the rate for HIV was 0.8%. 
In 2011, the prevalence of positive serology for 
hepatitis C, B and HIV was 5.5%, 1.1% and 
0.8%, respectively.
The estimated percentage of patients in 
hemodialysis with central venous catheter 
(temporary or permanent) was 14.5% and in 
use of vascular graft (graft) was 4.1%. In the 
evaluated sample (n = 38,198) in July 2012, 
the monthly rate of hospitalization was 5.7%. 
Concerning laboratory indices recommended for 
dialysis patients,1,2 Figure 4 shows that, among 
patients on hemodialysis, 21% had Kt/V < 1.2 
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Figure 4. Percentage of patients with tests not showing compliance 
with the recommended indices of 2010-12, census 2012.
or urea reduction ratio < 65%; 15% of patients 
had serum albumin < 3.5 g/dL; 37% had serum 
phosphorus > 5.5 mg/dL; PTH 29% greater 
300 pg/ml; and 21% had values above 600 pg/ml, 
and 17% with less than 100 pg/ml. Thirty-four 
percent had hemoglobin < 11 g/dl and 25% had 
values lower than 10 mg/dL.
Figure 5 shows the percentage of use of some 
selected medications in these patients: 80% were 
using erythropoietin; 56% intravenous iron; 32% 
vitamin D; 39% sevelamer, and only 1.3% used 
cinacalcet.
Figure 5. Percentage of patients using the selected medication in 
2010-12, census 2012.
The estimated number of patients enrolled on 
the waiting list for transplantation in July 2012 
was 30,447, equivalent to 31.2%.
The estimated number of deaths in 2012 was 
18,333, corresponding to a gross mortality rate 
(with the dialysis population on July 1 in the 
denominator) of 18.8% during the year.
discussion
The results of this report include the participation 
of 39% of active dialysis centers in the country. 
Although lower than in previous years (55% 
in 2011),3 this percentage has a substantial 
representation in the national territory and, 
although the sample of centers that responded 
was voluntary, it boasts a percentage distribution 
similar to the overall distribution of dialysis centers 
for the region in the country, which leads us to 
make inferences about the national generalization 
of the results. The best way to interpret our data 
is to observe trends over previous years. Estimates 
indicate an increase in the number of new patients 
(incidence) and the number of patients on dialysis 
(prevalence) in 2012 compared to recent years. For 
instance, the number of patients on treatment has 
increased by 3% per year since 2010. Our annual 
estimates should be interpreted with caution due 
to the variable response rate from the centers and 
the way of answering the questions, which require 
further validation. We have consistently reported 
variability in rates of prevalence and incidence by 
region of the country. This year in particular, we 
observed a higher prevalence rate in the Midwest 
region, unlike last year, which indicated a higher 
rate in the Southeast. This year’s estimate should 
be interpreted with caution, because the Midwest 
was one that showed a lower response rate (30%), 
which may cause bias in the estimates. There has 
been an increase on the prevalence rate reported 
in the United States and other developed coun-
tries in Europe and Asia, although the incidence 
of patients on renal replacement therapy has 
increased little or tended to stabilization.4 In USA 
for instance, the prevalence rate has increased 
around 2% in the last 8 years.4
The overall prevalence rate of dialysis 
(503/pmp) should be added to that of patients 
with functioning kidney graft (about 200/pmp) to 
obtain the actual rate of renal replacement therapy, 
which should be around 700/pmp. This latter rate 
is still lower than that of countries such as Chile 
(1.100/pmp), Argentina (800/pmp) and of some 
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developed countries in Europe that are around 
900-1.000/pmp, and also the U.S., 1870/pmp 
in 2010.4 However, as there are large regional 
variations in Brazil, the rate of the Southeast and 
South regions, for instance, must be very close 
to that of developed countries. Approximately 
34,000 patients (177/pmp) initiated chronic 
dialysis treatment in 2012. Similarly to the 
prevalence rates, we also observed large regional 
variability in incidence rates. The actual rate of 
incident patients must be achieved by adding the 
recipients of pre-emptive transplantation, and this 
seems similar to that observed in many European 
countries, although still way behind that of the 
United States (369/pmp) and Japan (288/pmp).4
In 2012 we found a substantially higher 
percentage of children and adolescents on 
dialysis compared to 2011 (4.5% vs. 1.6%, 
respectively), which should be confirmed in other 
studies. The percentage of 91.6% of patients on 
maintenance hemodialysis had a slight tendency 
to increase compared to that observed in previous 
censuses. Noteworthy, is the higher percentage 
of patients on APD and on daily hemodialysis 
among those subsidized by healthcare insurance 
plans, although the latter still represents less 
than 1% of all dialysis patients. The percentage 
of patients using venous catheter as access for 
hemodialysis remained constant (14.5%), and 
for the first time we estimated the percentage of 
patients in hemodialysis using vascular grafts, 
which was 4.1%. Hypertensive nephropathy 
is the principal underlying disease, followed 
by diabetes. A positive serology for hepatitis C 
continues decreasing annually; hepatitis B and 
HIV are stable. The percentage of patients with 
tests that did not comply with the international 
guidelines1,2 was generally similar in all indica-
tors measured vis-à-vis the year 2011. However, 
the percentage of patients with hemoglobin 
< 11 g/dl decreased from 39% in 2011 to 34% 
in 2012. In that year, we found that 25% of 
patients had hemoglobin levels below 10 g/dl 
which corresponds to the most recently recom-
mended target value. The percentage number of 
patients using erythropoietin and intravenous 
iron has also kept high. The high percentage 
of patients with anemia and high levels of 
phosphorus and PTH compared to those recom-
mended in the guidelines has also been observed 
in other developed countries in Europe, as well 
as in the United States and Japan.5,6 The lack of 
adaptation observed in a significant percentage 
of patients concerning indicators of mineral 
metabolism disorders (phosphorus and PTH) 
occur despite the high number of patients on se-
velamer (39%) and vitamin D (32%), apart from 
showing the recent onset of cinacalcet use in our 
country. The gross mortality rate showed a slight 
decrease compared to 2011 (18.8% vs. 19.9%), 
which should be seen as a positive indicator of 
treatment efficacy. In the last year, compared to 
2011, the percentage of patients with diabetic 
nephropathy and elderly subjects was stable, re-
vealing that there was no increased risk of overall 
mortality due to these factors. The mortality rate 
observed in Brazil remains below what has been 
reported for the U.S. population on dialysis.4
The generalizations in this study should be 
interpreted with caution due to the percentage 
of centers that responded to the survey, the data 
collection procedure on groups of patients per 
center and the lack of validation vis-à-vis the 
responses sent.
conclusion
The SBN census is an initiative of fundamental 
importance for understanding dialysis treatment 
in our country. This report provides information 
for the improvement of care for patients with 
chronic end-stage kidney disease and the national 
planning policy regarding chronic dialysis 
treatment in Brazil.
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